Dr Moro needs to develop point of care tests for monitoring with each current marker with the addition of recaf to boost their results. That would unbelievable! What management has been conveying is they are utilizing recaf in so many different ways and all have proven successful, so it is only a matter of time before recaf becomes an important utilized tool in modern medicine. Someone is squirming. Isn't it strange that Gaboy and I are limited to 1 post a day, and Mata a whopping 2 posts a day? Hmmmmmm?
IMO, Inverness will make a move and try and buy the company. Recaf just fits too perfectly in their arsenal of diagnostics. The fact that recaf can be used to monitor cancer, boosts current markers, is an inexpensive test, a POC test is on the horizon, and recently found additional indications in an untapped market by crossing over into veterinary medicine is just too compelling at these low levels. I just don't think Dr Moro will sell. (The recent stock options enabling management to buy shares at a 40% premium just last week has me thinking something is going on).
